Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Ensysce Biosciences Announces $5M Registered Direct Offering And Concurrent Private Placement, Issuing 3.55M Shares Of Common Stock And Warrants At $0.47 Per Share; Proceeds To Support Development Of Abuse-Deterrent Opioid PF614-MPAR And Other Programs

Author: Benzinga Newsdesk | August 29, 2024 08:05am

Posted In: ENSC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist